Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
Stingl JC, Ettrich T, Muche R, Wiedom M, Brockmöller J, Seeringer A, Seufferlein T. Stingl JC, et al. Among authors: seufferlein t. BMC Cancer. 2011 Aug 18;11:360. doi: 10.1186/1471-2407-11-360. BMC Cancer. 2011. PMID: 21851602 Free PMC article. Clinical Trial.
Population nutrikinetics of green tea extract.
Scholl C, Lepper A, Lehr T, Hanke N, Schneider KL, Brockmöller J, Seufferlein T, Stingl JC. Scholl C, et al. Among authors: seufferlein t. PLoS One. 2018 Feb 21;13(2):e0193074. doi: 10.1371/journal.pone.0193074. eCollection 2018. PLoS One. 2018. PMID: 29466429 Free PMC article. Clinical Trial.
High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors.
Hasheminasab SM, Tzvetkov MV, Schumann C, Rüdiger S, Boeck S, Heinemann V, Kächele V, Steffens M, Scholl C, Hichert V, Seufferlein T, Brockmöller J, Stingl JC. Hasheminasab SM, et al. Among authors: seufferlein t. Pharmacogenomics. 2015;16(14):1605-19. doi: 10.2217/pgs.15.97. Epub 2015 Sep 30. Pharmacogenomics. 2015. PMID: 26419366
Personalising drug safety-results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED).
Just KS, Dormann H, Böhme M, Schurig M, Schneider KL, Steffens M, Dunow S, Plank-Kiegele B, Ettrich K, Seufferlein T, Gräff I, Igel S, Schricker S, Jaeger SU, Schwab M, Stingl JC. Just KS, et al. Among authors: seufferlein t. Eur J Clin Pharmacol. 2020 Mar;76(3):439-448. doi: 10.1007/s00228-019-02797-9. Epub 2019 Dec 12. Eur J Clin Pharmacol. 2020. PMID: 31832731
The phenotype of adverse drug effects: Do emergency visits due to adverse drug reactions look different in older people? Results from the ADRED study.
Just KS, Dormann H, Schurig M, Böhme M, Steffens M, Plank-Kiegele B, Ettrich K, Seufferlein T, Gräff I, Igel S, Schricker S, Jaeger SU, Schwab M, Stingl JC. Just KS, et al. Among authors: seufferlein t. Br J Clin Pharmacol. 2020 Nov;86(11):2144-2154. doi: 10.1111/bcp.14304. Epub 2020 Apr 24. Br J Clin Pharmacol. 2020. PMID: 32250457 Free PMC article.
441 results